Myocardial-directed overexpression of the human β1-adrenergic receptor in transgenic mice

被引:213
|
作者
Bisognano, JD
Weinberger, HD
Bohlmeyer, TJ
Pende, A
Raynolds, MV
Sastravaha, A
Roden, R
Asano, K
Blaxall, BC
Wu, SC
Communal, C
Singh, K
Colucci, W
Bristow, MR
Port, JD
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Cardiol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[3] Boston Univ, VA Med Ctr, Div Cardiol, Boston, MA 02118 USA
关键词
beta adrenergic receptors; transgenic mice; heart failure; apoptosis;
D O I
10.1006/jmcc.2000.1123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The beta(1)-adrenergic receptor (AR) is the dominant subtype in non-failing and Failing myocardium. beta(1)-AR signaling, by the endogenous neurotransmitter norepinephrine, is central to the regulation of myocardial contractility. In heart failure, the beta(1)-AR undergoes subtype-selective downregulation which may protect, against the increased cardiac adrenergic drive associated with this pathophysiological stale. To examine the hypothesis that chronically increased beta(1)-AR mediated signaling has adverse myocardial effects, transgenic mice overexpressing the human beta(1)-AR in a cardiac-selective context were produced, utilizing an alpha-myosin heavy chain (MHC) promoter. In these mice, beta(1)-AR protein abundance was similar to 24-46-fold (1-2 pmol/mg protein) that of wild-type mice. Histopathological examination of young (4 months old) and old (greater than or equal to 9 months old) transgenic mouse hearts consistently demonstrated large areas of interstitial replacement fibrosis, marked myocyte hypertrophy and myofibrilar disarray. In addition, increased expression of the pre-apoptotic marker. Bax, was observed coincident with regions of fibrosis accompanied by an increased apoptotic index, as measured by TUNEL assay. Older non-transgenic mice exhibited a slight tendency towards a decreased fractional shortening, whereas older beta(1)-AR transgenic mice had a marked reduction in fractional shortening (%FS similar to 30) as determined by echocardiography. Additionally, older beta(1)-AR transgenic mice had an increased left ventricular chamber size. In summary, cardiac-directed overexpression of the human beta(1)-AR in transgenic mice leads to a significant histopathological phenotype with no apparent functional consequence in younger mice and a variable degree of cardiac dysfunction in older animals. This model system may ultimately prove useful for investigating the biological basis of adrenergically-mediated myocardial damage in humans. (C) 2000 Academic Press.
引用
收藏
页码:817 / 830
页数:14
相关论文
共 50 条
  • [21] α1-Adrenergic Receptor Subtypes in Nonfailing and Failing Human Myocardium
    Jensen, Brian C.
    Swigart, Philip M.
    De Marco, Teresa
    Hoopes, Charles
    Simpson, Paul C.
    CIRCULATION-HEART FAILURE, 2009, 2 (06) : 654 - 663
  • [22] A monoclonal antibody directed against an autoimmune epitope on the human β1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy
    Mobini, R
    Fu, M
    Wallukat, G
    Magnusson, Y
    Hjalmarson, Å
    Hoebeke, J
    HYBRIDOMA, 2000, 19 (02): : 135 - 142
  • [23] Radioiodinated α1-adrenergic receptor ligands
    Hamill, TG
    Burns, HD
    Gibson, RE
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2001, 44 (01): : 61 - 72
  • [24] Inhibition of Na+-H+ exchange prevents hypertrophy, fibrosis, and heart failure in β1-adrenergic receptor transgenic mice
    Engelhardt, S
    Hein, L
    Keller, U
    Klämbt, K
    Lohse, MJ
    CIRCULATION RESEARCH, 2002, 90 (07) : 814 - 819
  • [25] Transgenic mice with overexpression of human scavenger receptor A on endothelial cells
    Wan, LX
    Chung, SK
    Yang, YZ
    Chung, SSM
    Cao, DL
    Ma, M
    Wu, MJ
    Wang, ZY
    Chen, X
    CHINESE MEDICAL JOURNAL, 2001, 114 (10) : 1078 - 1083
  • [26] Caution with β1-adrenergic receptor genotyping
    Lanfear, DE
    Marsh, S
    McLeod, HL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (02) : 185 - 186
  • [27] Autoantibodies directed against the human β1-adrenergic receptor are associated with twofold increased mortality in dilated but not in ischemic cardiomyopathy
    Boivin, V
    Störk, S
    Horf, R
    Hein, L
    Angermann, CE
    Lohse, MJ
    Jahns, R
    HEART, 2004, 90 : A16 - A16
  • [28] ß1-adrenergic receptor blockade and cardiac ß2 overexpression stimulates angiogenesis in the failing heart
    Rengo, Giuseppe
    Maugeri, Fondazione S.
    Leosco, Dario
    Iaccarino, Guido
    Golino, Luca
    Cimini, Vincenzo
    Altobelli, Giovanna G.
    Sanzari, Emma
    Matrone, Gianfranco
    Zincarelli, Carmela
    Fortrunato, Francesca
    Koch, Walter J.
    Rengo, Franco
    CIRCULATION, 2006, 114 (18) : 49 - 49
  • [29] Hypertension and α1-adrenergic receptor subtype
    Tsujimoto, G
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 363 - 363
  • [30] Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats
    Jahns, Roland
    Boivin, Valerie
    Lohse, Martin J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 112 (01) : 7 - 14